Search

Search Constraints

You searched for: Author/Creator Ellezam, Benjamin

Search Results

2. Astrocytes in the Pathogenesis of Multiple Sclerosis: An In Situ MicroRNA Study. Issue 12 (23rd September 2019)

3. Autoantibody profiles delineate distinct subsets of scleromyositis. (19th June 2021)

4. Capillary pathology with prominent basement membrane reduplication is the hallmark histopathological feature of scleromyositis. (12th August 2022)

5. Clinical phenotypes and prognostic features of embryonal tumours with multi-layered rosettes: a Rare Brain Tumor Registry study. (November 2021)

6. CTNI-04. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PEDIATRIC PATIENTS WITH NEUROFIBROMATOSIS TYPE 1 AND PLEXIFORM NEUROFIBROMAS. (14th November 2022)

7. CTNI-06. TRAM-01: A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. (12th November 2021)

8. CTNI-24. A PHASE 2 STUDY OF TRAMETINIB FOR PATIENTS WITH PEDIATRIC GLIOMA WITH ACTIVATION OF THE MAPK/ERK PATHWAY. TRAM-01. (9th November 2020)

9. CTNI-67. EFFICACY AND SAFETY OF LAROTRECTINIB IN PATIENTS WITH TROPOMYOSIN RECEPTOR KINASE (TRK) FUSION PRIMARY CENTRAL NERVOUS SYSTEM (CNS) TUMORS: AN EXPANDED DATASET. (9th November 2020)